Insulin and Hormone Vial Seals and Closures

Q: What seal is best for a multidose insulin vial?

A flip-off seal such as the [FlipTop® Optima](/products/fliptop-seals/optima/) suits multidose insulin vials: you flip the plastic button to expose a central injection point, the stopper is punctured for each dose, and the aluminium stays crimped so the seal holds across the in-use life of the vial. The 13 mm size is common for insulin, and the Button design adds intrinsic tamper evidence.

Q: What does USP cover for insulin and hormone vials?

[USP ](/standards/usp-381/), Elastomeric Closures for Injections, evaluates the stopper properties that matter for repeated puncture, including self-sealing capacity, fragmentation and penetrability. It applies to the stopper rather than the aluminium seal, but the two work together to hold container closure integrity across many doses.

Insulin and Hormone Vial Seals and Closures

Insulin and many hormone products are multidose vials that are punctured repeatedly over days or weeks, so the closure has to hold its crimp through many needle passes, support the stopper that has to reseal each time, and give clear tamper evidence, most often on a 13 mm or 20 mm neck. The seal is what keeps the aluminium tight while the stopper does the resealing work between doses.

This page is for insulin and hormone formulators, packaging engineers and sourcing managers selecting a vial closure. It covers repeated puncture and reseal, the role of the elastomeric closure under USP <381>, tamper evidence, the Autofits seals that fit, and the standards involved.

Key takeaways

Insulin and hormone vials are typically multidose, punctured repeatedly, so the closure must hold its crimp while the stopper reseals between doses.
Resealing is a property of the elastomeric stopper, evaluated under USP <381>; the seal keeps that stopper compressed against the glass across the in-use period.
The FlipTop® Optima flip-off seal in 13 mm and 20 mm is the default; the Button design adds intrinsic tamper evidence.
All seals are supplied Ready-to-Use (gamma or ETO sterilized) or Ready-to-Sterilize, so they suit aseptic fill lines.
Closure standards: ISO 8362-6, ISO 15378, USP <381> and USP <1207>.

What insulin and hormone packaging needs from the closure

An insulin or hormone vial is a sterile container-closure system: glass vial, rubber stopper and an aluminium-plastic seal that crimps under the neck flange to compress the stopper against the glass. Multidose use puts particular weight on two requirements.

Repeated access. Insulin and many hormone products are multidose vials used over an extended in-use period, so the stopper is punctured many times. The closure has to allow that while the seal stays intact between doses. A flip-off seal suits this well: the user flips the plastic button to expose a small central injection point, the needle goes through the stopper, and the aluminium stays crimped so the seal holds across the in-use life of the vial.

Tamper evidence. A multidose vial in home or clinic use must show whether it has been opened. A flipped or missing button signals an opened seal; the Optima Button design carries intrinsic tamper evidence via a 12-stem flower formed under the button disc, so the opened state is visibly distinct.

Repeated puncture and reseal, and the USP <381> tie-in

On a multidose vial the resealing happens at the stopper, not the seal. Each time the needle is withdrawn, the elastomeric stopper has to close the puncture channel so the vial stays sterile and the contents stay protected across the in-use period. That resealing behaviour, along with self-sealing capacity, fragmentation and penetrability, is evaluated under USP <381>, Elastomeric Closures for Injections.

The aluminium seal has a different but complementary job: it must keep the stopper compressed against the glass with a tight crimp so the stopper can do its resealing work and the container closure integrity holds across many punctures. The aluminium-plastic construction, an AA8011 aluminium shell with a polypropylene button and a mechanical crimp rather than an adhesive bond, keeps that compression stable across the in-use life. Container closure integrity through the in-use period should be confirmed for the specific product against USP <1207>.

Which Autofits seals fit insulin and hormone vials

For insulin and hormone vials, the FlipTop® Optima flip-off seal is the default closure:

13 mm Optima suits small-volume insulin and hormone vials. The 13 mm seal has a total height of 7.62 to 8.38 mm, six tapered bridges and a maximum opening force of 30 N.
20 mm Optima suits larger multidose vials. The 20 mm seal has a total height of 9.02 to 9.91 mm, six tapered bridges and a maximum opening force of 35 N.
The Button design adds intrinsic tamper evidence; colour coding is available in a wide range of colours, matte or glossy, customised to requirement, which helps distinguish insulin strengths and hormone products.

All seals are supplied Regular, Ready-to-Use (gamma or ETO sterilized, double-bagged for aseptic areas) or Ready-to-Sterilize, so they slot into both terminal and aseptic fill lines. See the FlipTop® Optima page or the applications hub for the full range.

Relevant standards

ISO 8362-6: the design standard for caps made of aluminium-plastics combinations for injection vials, which the Optima follows. Vial necks follow ISO 8362-1.
ISO 15378: GMP requirements for primary packaging materials; Autofits seals are produced under ISO 15378:2017.
USP <381>: elastomeric closures for injections, which evaluates self-sealing, fragmentation and penetrability of the stopper that the seal crimps over on a multidose vial.
USP <1207>: package integrity evaluation for sterile products, the reference for demonstrating container closure integrity across the in-use period.

Frequently asked questions

What seal is best for a multidose insulin vial?

A flip-off seal such as the FlipTop® Optima suits multidose insulin vials: you flip the plastic button to expose a central injection point, the stopper is punctured for each dose, and the aluminium stays crimped so the seal holds across the in-use life of the vial. The 13 mm size is common for insulin, and the Button design adds intrinsic tamper evidence.

How does a multidose vial reseal after each puncture?

Resealing happens at the elastomeric stopper, not the aluminium seal. When the needle is withdrawn, the stopper closes the puncture channel so the vial stays sterile. That self-sealing behaviour is evaluated under USP <381>. The aluminium seal keeps the stopper compressed against the glass so it can do this work.

What does USP <381> cover for insulin and hormone vials?

USP <381>, Elastomeric Closures for Injections, evaluates the stopper properties that matter for repeated puncture, including self-sealing capacity, fragmentation and penetrability. It applies to the stopper rather than the aluminium seal, but the two work together to hold container closure integrity across many doses.

What size seal do insulin and hormone vials use?

Insulin and hormone vials most often use 13 mm for small volumes and 20 mm for larger multidose presentations. Match the seal to the vial finish and the stopper of the same nominal diameter; the 13 mm and 20 mm Optima pages list dimensions to check against your vial.

How does the seal provide tamper evidence on a multidose vial?

A flip-off seal shows it has been opened once the plastic button is flipped or missing. The Optima Button design adds intrinsic tamper evidence with a 12-stem flower formed under the button disc, so the opened state is visibly distinct.

Sources

Autofits FlipTop Seals dossier and engineering drawings (working/spec-sheets/)
ISO: ISO 8362-6:2010, Injection containers and accessories, Part 6: Caps made of aluminium-plastics combinations for injection vials (https://www.iso.org/standard/45641.html)
ISO: ISO 15378:2017, Primary packaging materials for medicinal products, GMP requirements (https://www.iso.org/standard/70845.html)
USP-NF: General Chapter <381>, Elastomeric Closures for Injections (https://www.usp.org/)
USP-NF: General Chapter <1207>, Package Integrity Evaluation, Sterile Products (https://www.usp.org/)

“`json { “@context”: “https://schema.org”, “@graph”: [ { “@type”: “Article”, “headline”: “Insulin and Hormone Vial Seals and Closures”, “description”: “How to select a vial seal for multidose insulin and hormone products, covering repeated puncture and reseal, the USP <381> tie-in for the elastomeric stopper, tamper evidence and container closure integrity, with suggested Autofits closures.”, “author”: {“@type”: “Organization”, “name”: “Autofits Technical Team”}, “publisher”: { “@type”: “Organization”, “name”: “Autofits Packaging Pvt. Ltd.”, “address”: { “@type”: “PostalAddress”, “streetAddress”: “E-13/7/4, MIDC, Malegaon, Sinnar”, “addressLocality”: “Nashik”, “addressCountry”: “IN” } }, “datePublished”: “2026-07-06”, “dateModified”: “2026-07-06” }, { “@type”: “FAQPage”, “mainEntity”: [ {“@type”: “Question”, “name”: “What seal is best for a multidose insulin vial?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “A flip-off seal such as the FlipTop Optima suits multidose insulin vials: you flip the plastic button to expose a central injection point, the stopper is punctured for each dose, and the aluminium stays crimped so the seal holds across the in-use life of the vial. The 13 mm size is common for insulin, and the Button design adds intrinsic tamper evidence.”}}, {“@type”: “Question”, “name”: “How does a multidose vial reseal after each puncture?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Resealing happens at the elastomeric stopper, not the aluminium seal. When the needle is withdrawn, the stopper closes the puncture channel so the vial stays sterile. That self-sealing behaviour is evaluated under USP <381>. The aluminium seal keeps the stopper compressed against the glass so it can do this work.”}}, {“@type”: “Question”, “name”: “What does USP <381> cover for insulin and hormone vials?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “USP <381>, Elastomeric Closures for Injections, evaluates the stopper properties that matter for repeated puncture, including self-sealing capacity, fragmentation and penetrability. It applies to the stopper rather than the aluminium seal, but the two work together to hold container closure integrity across many doses.”}}, {“@type”: “Question”, “name”: “What size seal do insulin and hormone vials use?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Insulin and hormone vials most often use 13 mm for small volumes and 20 mm for larger multidose presentations. Match the seal to the vial finish and the stopper of the same nominal diameter.”}}, {“@type”: “Question”, “name”: “How does the seal provide tamper evidence on a multidose vial?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “A flip-off seal shows it has been opened once the plastic button is flipped or missing. The Optima Button design adds intrinsic tamper evidence with a 12-stem flower formed under the button disc, so the opened state is visibly distinct.”}} ] }, { “@type”: “BreadcrumbList”, “itemListElement”: [ {“@type”: “ListItem”, “position”: 1, “name”: “Home”, “item”: “/”}, {“@type”: “ListItem”, “position”: 2, “name”: “Applications”, “item”: “/applications/”}, {“@type”: “ListItem”, “position”: 3, “name”: “Insulin and Hormones”, “item”: “/applications/insulin-and-hormones/”} ] } ] } “`

*Last updated: 2026-07-06. This page is general technical information, not regulatory or compliance advice; confirm current standard editions and your own specification with Autofits and the issuing bodies.*